Inventor
EMANUEL STUART
US20 patents
⚠️ This page may combine multiple inventors who share the name “EMANUEL STUART”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS9017655B2Apr 28, 2015
Bispecific EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO36 citations97
US8343501B2Jan 1, 2013
Bispecific EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO45 citations97
US9920108B2Mar 20, 2018
Targeted therapeutics based on engineered proteins that bind EGFR
BRISTOL MYERS SQUIBB CO19 citations93
US9771411B2Sep 26, 2017
Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO22 citations93
US9234028B2Jan 12, 2016
Targeted therapeutics based on engineered proteins that bind EGFR
BRISTOL MYERS SQUIBB CO30 citations93
US10183987B2Jan 22, 2019
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules
BRISTOL MYERS SQUIBB CO7 citations83
US10954286B2Mar 23, 2021
Bispecific EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO2 citations72
US10781247B2Sep 22, 2020
Targeted therapeutics based on engineered proteins that bind EGFR
BRISTOL MYERS SQUIBB CO3 citations72
JANSSEN BIOTECH INC
4 patentsUS11472830B2Oct 18, 2022
Cyclic dinucleotides as sting agonists
JANSSEN BIOTECH INC0 citations61
US11021511B2Jun 1, 2021
Cyclic dinucleotides as sting agonists
JANSSEN BIOTECH INC0 citations61
US11597746B2Mar 7, 2023
Cyclic dinucleotides as sting agonists
JANSSEN BIOTECH INC1 citations60
US11492367B2Nov 8, 2022
Cyclic dinucleotides as sting agonists
JANSSEN BIOTECH INC0 citations59
JANSSEN PHARMACEUTICA NV
3 patentsUS7541367B2Jun 2, 2009
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
JANSSEN PHARMACEUTICA NV104 citations97
US7795440B2Sep 14, 2010
N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
JANSSEN PHARMACEUTICA NV0 citations48
US7109220B2Sep 19, 2006
Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
JANSSEN PHARMACEUTICA NV0 citations40